Company / SG&A per Share
Bristol Myers Squibb SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.50
FY2025
5-year range
$2.85 / $3.92
FY2021-FY2025
Trend
-10.8%
vs FY2024
Sector context
#51 of 210
Health Care
What the data says
Bristol Myers Squibb's sg&a per share of $3.50 is higher than 76% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $2.83 in FY2017 to $4.68 in FY2020.
Based on SEC 10-K filings.
3.50 in FY2025 with a 5-year CAGR of -5.7%. Top quartile in the Health Care sector.
Increased from $3.43 to $3.50 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- -5.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 210This company $3.50 Sector average $40.75
▼
-91.4% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 10.8% year-over-year.
- Ranks #51 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.50 | -10.8% |
| FY2024 | $3.92 | +14.5% |
| FY2023 | $3.43 | +1.0% |
| FY2022 | $3.39 | +19.2% |
| FY2021 | $2.85 | -39.2% |
| FY2020 | $4.68 | +62.7% |
| FY2019 | $2.88 | -3.0% |
| FY2018 | $2.96 | +4.7% |
| FY2017 | $2.83 | -2.0% |
| FY2016 | $2.89 | -2.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026